MedPath

A study to know the efficacy of dexmeditomidine as an anti shivering agent after spinal anaesthesia.

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/02/039937
Lead Sponsor
Dr Reema Rajshekhar Wali
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.ASA physical status I and II.

2.Age between 18 to 65 years.

3.Patient undergoing surgeries under spinal anaesthesia.

Exclusion Criteria

1.Allergic to the study drugs-bupivacaine and dexmedetomidine

2.A Pre-Operative baseline temperature of more than 37.5 degreeCelsius

3.Patients on long standing opioids

4.Patients suffering from thyroid disorders

5.Patient undergoing surgeries like TURP, where irrigation fluids are used

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study the efficacy of dexmedetomidine in prevention of shivering in adult patients undergoing surgeries under spinal anaesthesiaTimepoint: 10 minutes from Time of Spinal Injection to 180 minutes
Secondary Outcome Measures
NameTimeMethod
To know the side effects of dexmedetomidineTimepoint: From time of Spinal Injection to 180 minutes
© Copyright 2025. All Rights Reserved by MedPath